Deborah Mukherji· @dmukherji · X·· 23 hours agoScore70
Body
PROTEUS substudy results at #ESMO26
Perioperative apalutamide + ADT vs surgery alone in high-risk localized #ProstateCancer
EFS HR 0.38
MFS HR 0.49
Subsequent treatment at 3 years: 35% vs 68%
Compelling evidence for perioperative intensification @OncoAlert
165 views · 6 likes · 6 reposts · 1 reply
Replies in this thread
- Paul Sargos@PaulSargos
@dmukherji @OncoAlert Evidence? Which level?
Source: Deborah Mukherji · x.com